首页 > 最新文献

Global advances in integrative medicine and health最新文献

英文 中文
Moral Distress as a Critical Driver of Burnout in Medicine.
Pub Date : 2025-03-17 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251325462
Amy Locke, Tanya L Rodgers, Margaret L Dobson

There are many known drivers of burnout and distress among physicians and other healthcare providers. Current conversations have not fully characterized the significant impact of workload increases alongside staffing shortages as drivers of moral distress and subsequent burnout. Together these factors pose a significant systemic threat to the workforce, and a personal threat to the individuals within it. Physicians are at high risk for moral distress because of work ethic and culture. The drive to do the right thing for the patient limits an ability to set boundaries around work. Moral distress is experienced when the needs of patients can't be met; this drives us to work even harder. Culturally, there has been limited opportunity to acknowledge this distress, so we haven't been able to deal with it outright. Financial pressures continue pressure health systems to drive productivity. Additional patient encounters drive more after visit work that requires time and attention. Simultaneously, the remaining physicians are further stretched as people burnout and leave. There are few groups of workers more mission-driven than primary care physicians. We are committed to doing the right thing for patients and our teams. If we can acknowledge and talk about moral distress as an indicator that we need to change the way we do things, we can use it as a tool to optimize patient care. The physician voice may help us move beyond the learned helplessness and shift to engagement in solutions. We propose three solutions: 1) acknowledge the presence of routinized stress injury that occurs in healthcare 2) leverage data on physician wellbeing to understand how to optimize care, and 3) foster connection and community. Fundamentally, when our healthcare workers feel seen, heard, and valued, they are healthier themselves, and better able to support the missions of the medical system.

{"title":"Moral Distress as a Critical Driver of Burnout in Medicine.","authors":"Amy Locke, Tanya L Rodgers, Margaret L Dobson","doi":"10.1177/27536130251325462","DOIUrl":"10.1177/27536130251325462","url":null,"abstract":"<p><p>There are many known drivers of burnout and distress among physicians and other healthcare providers. Current conversations have not fully characterized the significant impact of workload increases alongside staffing shortages as drivers of moral distress and subsequent burnout. Together these factors pose a significant systemic threat to the workforce, and a personal threat to the individuals within it. Physicians are at high risk for moral distress because of work ethic and culture. The drive to do the right thing for the patient limits an ability to set boundaries around work. Moral distress is experienced when the needs of patients can't be met; this drives us to work even harder. Culturally, there has been limited opportunity to acknowledge this distress, so we haven't been able to deal with it outright. Financial pressures continue pressure health systems to drive productivity. Additional patient encounters drive more after visit work that requires time and attention. Simultaneously, the remaining physicians are further stretched as people burnout and leave. There are few groups of workers more mission-driven than primary care physicians. We are committed to doing the right thing for patients and our teams. If we can acknowledge and talk about moral distress as an indicator that we need to change the way we do things, we can use it as a tool to optimize patient care. The physician voice may help us move beyond the learned helplessness and shift to engagement in solutions. We propose three solutions: 1) acknowledge the presence of routinized stress injury that occurs in healthcare 2) leverage data on physician wellbeing to understand how to optimize care, and 3) foster connection and community. Fundamentally, when our healthcare workers feel seen, heard, and valued, they are healthier themselves, and better able to support the missions of the medical system.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251325462"},"PeriodicalIF":0.0,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11915272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143659988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Prospective, Interventional, Randomized, Double-Blinded, Placebo-Controlled, Monocentric Clinical Study to Evaluate the Efficacy and Safety of Alkalihalobacillus clausii 088AE in Resolution of Acute Allergic Rhinitis Symptoms. 一项前瞻性、干预性、随机、双盲、安慰剂对照、单中心临床研究,旨在评估碱性卤化杆菌 088AE 在缓解急性过敏性鼻炎症状方面的有效性和安全性。
Pub Date : 2025-03-14 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251321821
Abhijit Rathi, Rajeshree A Khaire, V L Rathi
<p><strong>Background: </strong>Allergic rhinitis (AR) is a common inflammatory disease of the upper respiratory tract mainly triggered by allergens such as dust mites, pollen, spores, and viral or bacterial infections. AR is primarily associated with symptoms such as nasal itching, sneezing, rhinorrhea, nasal congestion, and watery, itchy, or red eyes. AR significantly affects an individual's quality of life. Probiotics have been proven effective in the clinical management of AR through immunomodulation. However, studies on the use of <i>Alkalihalobacillus clausii</i> to alleviate the symptoms of AR have rarely been reported.</p><p><strong>Objective: </strong>This study aimed to explore the clinical efficacy, safety, and possible underlying mechanism of <i>Alkalihalobacillus clausii</i> 088AE in alleviating the associated symptoms of acute AR in patients.</p><p><strong>Methods: </strong>A prospective, interventional, randomized, double-blinded, placebo-controlled, monocentric clinical study was conducted on patients with acute AR (N = 40) randomized into two groups, test (N = 20) and placebo (N = 20). Patients in the test arm received a probiotic strain, <i>A. clausii</i> 088AE, whereas patients in the placebo arm received Maltodextrin. The primary endpoints (efficacy) were total 4 nasal symptoms scores (T4NSS), total 2 ocular symptoms scores (T2OSS), cough scores, and immunological parameters (T-helper 1 (Th1), Th2, Th17, and T-regulatory (Treg) cells, Interleukin (IL)-4, IL10, IL17, IL22, interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α) and -beta (TNF-β), and forkhead box P3 (FOXP3)) evaluated from baseline to end of treatment (EOT). The secondary endpoints (safety) assessed were vital physical signs, hematology, and biochemical parameters, along with an assessment of adverse or serious adverse events (AEs and SAEs).</p><p><strong>Results: </strong><i>A. clausii</i> 088AE supplementation significantly reduced the T4NSS (rhinorrhoea, nasal stuffiness, nasal itching, and sneezing; <i>P</i> < 0.001), T2OSS (itching and watery eyes; <i>P</i> < 0.001), and cough scores (<i>P</i> < 0.01) by the EOT compared to baseline. The placebo group reported a significant increase in all the above symptom scores at the EOT from their baseline values (<i>P</i> < 0.001). The intergroup analysis between <i>A. clausii</i> 088AE and placebo indicated a significant change in T4NSS, T2OSS, and cough score (<i>P</i> < 0.001). Further, the immunological parameters were improved (non-significant, <i>P</i>-value ≥ 0.05) with the probiotic supplementation. No adverse events (AEs) or serious adverse events (SAEs) leading to termination of study participation were reported with the use of <i>A. clausii</i> 088AE in the study. No clinically significant vital signs and physical examinations were reported as AEs or SAEs by the investigator.</p><p><strong>Conclusion: </strong><i>A. clausii</i> 088AE supplementation improved the clinical symptoms in patients with AR.
{"title":"A Prospective, Interventional, Randomized, Double-Blinded, Placebo-Controlled, Monocentric Clinical Study to Evaluate the Efficacy and Safety of <i>Alkalihalobacillus clausii</i> 088AE in Resolution of Acute Allergic Rhinitis Symptoms.","authors":"Abhijit Rathi, Rajeshree A Khaire, V L Rathi","doi":"10.1177/27536130251321821","DOIUrl":"https://doi.org/10.1177/27536130251321821","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Allergic rhinitis (AR) is a common inflammatory disease of the upper respiratory tract mainly triggered by allergens such as dust mites, pollen, spores, and viral or bacterial infections. AR is primarily associated with symptoms such as nasal itching, sneezing, rhinorrhea, nasal congestion, and watery, itchy, or red eyes. AR significantly affects an individual's quality of life. Probiotics have been proven effective in the clinical management of AR through immunomodulation. However, studies on the use of &lt;i&gt;Alkalihalobacillus clausii&lt;/i&gt; to alleviate the symptoms of AR have rarely been reported.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;This study aimed to explore the clinical efficacy, safety, and possible underlying mechanism of &lt;i&gt;Alkalihalobacillus clausii&lt;/i&gt; 088AE in alleviating the associated symptoms of acute AR in patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A prospective, interventional, randomized, double-blinded, placebo-controlled, monocentric clinical study was conducted on patients with acute AR (N = 40) randomized into two groups, test (N = 20) and placebo (N = 20). Patients in the test arm received a probiotic strain, &lt;i&gt;A. clausii&lt;/i&gt; 088AE, whereas patients in the placebo arm received Maltodextrin. The primary endpoints (efficacy) were total 4 nasal symptoms scores (T4NSS), total 2 ocular symptoms scores (T2OSS), cough scores, and immunological parameters (T-helper 1 (Th1), Th2, Th17, and T-regulatory (Treg) cells, Interleukin (IL)-4, IL10, IL17, IL22, interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α) and -beta (TNF-β), and forkhead box P3 (FOXP3)) evaluated from baseline to end of treatment (EOT). The secondary endpoints (safety) assessed were vital physical signs, hematology, and biochemical parameters, along with an assessment of adverse or serious adverse events (AEs and SAEs).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;&lt;i&gt;A. clausii&lt;/i&gt; 088AE supplementation significantly reduced the T4NSS (rhinorrhoea, nasal stuffiness, nasal itching, and sneezing; &lt;i&gt;P&lt;/i&gt; &lt; 0.001), T2OSS (itching and watery eyes; &lt;i&gt;P&lt;/i&gt; &lt; 0.001), and cough scores (&lt;i&gt;P&lt;/i&gt; &lt; 0.01) by the EOT compared to baseline. The placebo group reported a significant increase in all the above symptom scores at the EOT from their baseline values (&lt;i&gt;P&lt;/i&gt; &lt; 0.001). The intergroup analysis between &lt;i&gt;A. clausii&lt;/i&gt; 088AE and placebo indicated a significant change in T4NSS, T2OSS, and cough score (&lt;i&gt;P&lt;/i&gt; &lt; 0.001). Further, the immunological parameters were improved (non-significant, &lt;i&gt;P&lt;/i&gt;-value ≥ 0.05) with the probiotic supplementation. No adverse events (AEs) or serious adverse events (SAEs) leading to termination of study participation were reported with the use of &lt;i&gt;A. clausii&lt;/i&gt; 088AE in the study. No clinically significant vital signs and physical examinations were reported as AEs or SAEs by the investigator.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;&lt;i&gt;A. clausii&lt;/i&gt; 088AE supplementation improved the clinical symptoms in patients with AR.","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251321821"},"PeriodicalIF":0.0,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909684/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative Naturopathic Treatment Model for Colorectal Cancer: A Retrospective Study.
Pub Date : 2025-03-14 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251326572
Sara Izadi-Najafabadi, Lisa McQuarrie, Sarah Denotter, Mark Elderfield, Gurdev Parmar

Background: While specific elements of naturopathic medicine, such as botanical medicines and lifestyle interventions, have supporting evidence, there is limited quantitative data confirming its effectiveness as a comprehensive, whole-person medical approach for patients with metastatic colorectal cancer (CRC).

Objective: This study aims to retrospectively evaluate the integration of naturopathic modalities, including modulated electrohyperthermia (mEHT), into the standard of care for metastatic CRC. We compare survival outcomes between patients at the Integrated Health Clinic (IHC) and a matched control group from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database, a de-identified, publicly available cancer registry in the United States.

Methods: A retrospective chart review was conducted for 131 IHC patients diagnosed with stage IV CRC and treated with mEHT between 2010 and 2021. These patients were matched with 262 controls from the SEER database using propensity score matching. The primary outcome was overall survival, with time zero defined as the first IHC treatment date (with controls assigned the time zero of their matched IHC patient) to account for immortal time bias. Survival analysis was conducted using a Kaplan-Meier curve, log-rank test, and Cox proportional-hazards model.

Results: The overall survival analysis did not achieve a statistically significant difference (HR = .76; 95% CI: .57-1.01) between the IHC (median survival time: 29 month) and SEER groups (median survival time: 18 months). Incorporating time-varying effects, the hazard ratio (HR) for the IHC group compared to the SEER group was .63 (95% CI: .46-.86) for survival <36 months, indicating a lower hazard of early mortality in the IHC group. Moreover, IHC patients who initiated treatment within 90 days of diagnosis had significantly improved survival compared to their matched controls (HR = .45; 95% CI: .28-.70).

Conclusion: This study provides evidence that integrative naturopathic treatment, including mEHT, can significantly improve survival outcomes for CRC patients in the first 36 months post-treatment and when initiated within 90 days of diagnosis.

{"title":"Integrative Naturopathic Treatment Model for Colorectal Cancer: A Retrospective Study.","authors":"Sara Izadi-Najafabadi, Lisa McQuarrie, Sarah Denotter, Mark Elderfield, Gurdev Parmar","doi":"10.1177/27536130251326572","DOIUrl":"https://doi.org/10.1177/27536130251326572","url":null,"abstract":"<p><strong>Background: </strong>While specific elements of naturopathic medicine, such as botanical medicines and lifestyle interventions, have supporting evidence, there is limited quantitative data confirming its effectiveness as a comprehensive, whole-person medical approach for patients with metastatic colorectal cancer (CRC).</p><p><strong>Objective: </strong>This study aims to retrospectively evaluate the integration of naturopathic modalities, including modulated electrohyperthermia (mEHT), into the standard of care for metastatic CRC. We compare survival outcomes between patients at the Integrated Health Clinic (IHC) and a matched control group from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) database, a de-identified, publicly available cancer registry in the United States.</p><p><strong>Methods: </strong>A retrospective chart review was conducted for 131 IHC patients diagnosed with stage IV CRC and treated with mEHT between 2010 and 2021. These patients were matched with 262 controls from the SEER database using propensity score matching. The primary outcome was overall survival, with time zero defined as the first IHC treatment date (with controls assigned the time zero of their matched IHC patient) to account for immortal time bias. Survival analysis was conducted using a Kaplan-Meier curve, log-rank test, and Cox proportional-hazards model.</p><p><strong>Results: </strong>The overall survival analysis did not achieve a statistically significant difference (HR = .76; 95% CI: .57-1.01) between the IHC (median survival time: 29 month) and SEER groups (median survival time: 18 months). Incorporating time-varying effects, the hazard ratio (HR) for the IHC group compared to the SEER group was .63 (95% CI: .46-.86) for survival <36 months, indicating a lower hazard of early mortality in the IHC group. Moreover, IHC patients who initiated treatment within 90 days of diagnosis had significantly improved survival compared to their matched controls (HR = .45; 95% CI: .28-.70).</p><p><strong>Conclusion: </strong>This study provides evidence that integrative naturopathic treatment, including mEHT, can significantly improve survival outcomes for CRC patients in the first 36 months post-treatment and when initiated within 90 days of diagnosis.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251326572"},"PeriodicalIF":0.0,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909678/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial.
Pub Date : 2025-03-14 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251327134
Subramanian Pushkala, Sudha Seshayyan, Ethirajan Theranirajan, Doraisamy Sudhakar, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, Samuel Jk Abraham

Background: Several biomarkers, including C-reactive protein (CRP), ferritin, D-dimer, and Interleukin-6 (IL-6), are established predictors of disease severity and respiratory failure in patients with COVID-19.

Objective: In this randomised clinical study, we evaluated the efficiency of the combination of 2 variants' AFO-202 and N-163 strains of Aureobasidium pullulans produced 1,3-1,6 β-glucans in comparison with the control arm on these biomarkers in COVID-19 patients.

Methods: Forty RT-PCR positive COVID-19 patients were divided into 2 groups: control (n = 22) and standard treatment; ii. (n = 18) - Standard treatment + combination of AFO-202 and N-163 beta glucans for 15 days.

Results: IL-6 levels significantly decreased in the treatment group on day 7 (P = 0.03) but not by day 15 (P = 0.30). CRP levels in the treatment group decreased at day 7 (5.53 ± 8.21 mg/L) compared to baseline but showed no significant difference from the control group (4.91 ± 12.54 mg/L, P = 0.98). At day 15, CRP levels remained lower in the treatment group (5.42 ± 10.41 mg/L) but increased in the control group (14.0 ± 37.16 mg/L), with no significant difference (P = 0.52). Ferritin levels dropped significantly in the treatment group by day 15 (from 560.58 ± 537.30 ng/mL to 127.51 ± 215.91 ng/mL) but increased in the control (P = 0.98). D-dimer levels decreased in the treatment group by day 15 but were not significantly different from controls (P = 0.56).

Conclusion: These results indicate that while co-supplementation with AFO-202 and N-163 beta-glucans led to improvement in CRP, ferritin, and IL-6 levels in COVID-19 patients, only the reduction in IL-6 levels on day 7 reached statistical significance. Further long-term multicentric clinical research is warranted to validate the potential of these supplements as treatment adjuncts, for addressing inflammation in COVID-19, especially in vulnerable populations infected with emerging SARS-CoV-2 variants.

背景:一些生物标志物,包括C反应蛋白(CRP)、铁蛋白、D-二聚体和白细胞介素-6(IL-6),是COVID-19患者疾病严重程度和呼吸衰竭的既定预测指标:在这项随机临床研究中,我们评估了与对照组相比,两种变异株 AFO-202 和 N-163 Aureobasidium pullulans 产生的 1,3-1,6 β-葡聚糖组合对 COVID-19 患者这些生物标志物的影响:40名RT-PCR阳性的COVID-19患者分为两组:对照组(n=22)和标准治疗组;ii.(n=18)--标准治疗+AFO-202和N-163β葡聚糖联合治疗15天:结果:治疗组的 IL-6 水平在第 7 天明显下降(P = 0.03),但在第 15 天没有下降(P = 0.30)。治疗组的 CRP 水平在第 7 天(5.53 ± 8.21 mg/L)与基线相比有所下降,但与对照组(4.91 ± 12.54 mg/L,P = 0.98)相比无显著差异。在第 15 天,治疗组的 CRP 水平仍然较低(5.42 ± 10.41 mg/L),但对照组的 CRP 水平有所上升(14.0 ± 37.16 mg/L),差异不显著(P = 0.52)。到第 15 天,治疗组的铁蛋白水平明显下降(从 560.58 ± 537.30 纳克/毫升降至 127.51 ± 215.91 纳克/毫升),但对照组的铁蛋白水平有所上升(P = 0.98)。治疗组的 D-二聚体水平在第 15 天时有所下降,但与对照组无显著差异(P = 0.56):这些结果表明,虽然共同补充 AFO-202 和 N-163 β-葡聚糖可改善 COVID-19 患者的 CRP、铁蛋白和 IL-6 水平,但只有第 7 天 IL-6 水平的降低具有统计学意义。有必要开展进一步的长期多中心临床研究,以验证这些补充剂作为辅助治疗手段的潜力,从而解决 COVID-19 中的炎症问题,尤其是在感染了新出现的 SARS-CoV-2 变体的易感人群中。
{"title":"Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial.","authors":"Subramanian Pushkala, Sudha Seshayyan, Ethirajan Theranirajan, Doraisamy Sudhakar, Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Nobunao Ikewaki, Masaru Iwasaki, Senthilkumar Preethy, Samuel Jk Abraham","doi":"10.1177/27536130251327134","DOIUrl":"https://doi.org/10.1177/27536130251327134","url":null,"abstract":"<p><strong>Background: </strong>Several biomarkers, including C-reactive protein (CRP), ferritin, D-dimer, and Interleukin-6 (IL-6), are established predictors of disease severity and respiratory failure in patients with COVID-19.</p><p><strong>Objective: </strong>In this randomised clinical study, we evaluated the efficiency of the combination of 2 variants' AFO-202 and N-163 strains of <i>Aureobasidium pullulans</i> produced 1,3-1,6 β-glucans in comparison with the control arm on these biomarkers in COVID-19 patients.</p><p><strong>Methods: </strong>Forty RT-PCR positive COVID-19 patients were divided into 2 groups: control (n = 22) and standard treatment; ii. (n = 18) - Standard treatment + combination of AFO-202 and N-163 beta glucans for 15 days.</p><p><strong>Results: </strong>IL-6 levels significantly decreased in the treatment group on day 7 (<i>P</i> = 0.03) but not by day 15 (<i>P</i> = 0.30). CRP levels in the treatment group decreased at day 7 (5.53 ± 8.21 mg/L) compared to baseline but showed no significant difference from the control group (4.91 ± 12.54 mg/L, <i>P</i> = 0.98). At day 15, CRP levels remained lower in the treatment group (5.42 ± 10.41 mg/L) but increased in the control group (14.0 ± 37.16 mg/L), with no significant difference (<i>P</i> = 0.52). Ferritin levels dropped significantly in the treatment group by day 15 (from 560.58 ± 537.30 ng/mL to 127.51 ± 215.91 ng/mL) but increased in the control (<i>P</i> = 0.98). D-dimer levels decreased in the treatment group by day 15 but were not significantly different from controls (<i>P</i> = 0.56).</p><p><strong>Conclusion: </strong>These results indicate that while co-supplementation with AFO-202 and N-163 beta-glucans led to improvement in CRP, ferritin, and IL-6 levels in COVID-19 patients, only the reduction in IL-6 levels on day 7 reached statistical significance. Further long-term multicentric clinical research is warranted to validate the potential of these supplements as treatment adjuncts, for addressing inflammation in COVID-19, especially in vulnerable populations infected with emerging SARS-CoV-2 variants.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251327134"},"PeriodicalIF":0.0,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909674/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143652391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resiliency Among Mass General Brigham Hospital Employees Post-COVID-19 Pandemic.
Pub Date : 2025-03-04 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251325831
Natalie Durieux, Elyse R Park, Daniel Hall, Jocelyn Meek, Gregory Fricchione, Darshan H Mehta, Christina Luberto

Background: Healthcare workers face an elevated risk of chronic stress and burnout, for which resiliency interventions are needed.

Methods: The Stress Management and Resiliency Training Program (SMART-3RP; 8 weekly 90-minute sessions) was offered to 254 hospital employees between 2/2021 and 1/2024. Participants were surveyed pre- and post-intervention for measures of resiliency, stress coping, positive affect, perceived stress, anxiety, and depression.

Results: The baseline sample was 84% female, 89.5% non-Hispanic, 71.3% White, and averaged 45 years of age (SD = 14.25). Baseline and follow-up survey completion rates were 71.3% (N = 181) and 35.8% (N = 91), respectively. Significant improvements were seen pre-post intervention for all measures (all ps <.001): resiliency (d = 0.57), stress coping (d = 1.1), positive affect (d = 0.83), perceived stress (d = -0.88), anxiety (d = -0.74), and depression (d = -0.43).

Conclusions: Alleviating employee stress is crucial for improving individual, clinical, and systems-level outcomes in hospitals. The SMART-3RP is a promising program that provides healthcare workers with resiliency and stress coping skills.

{"title":"Resiliency Among Mass General Brigham Hospital Employees Post-COVID-19 Pandemic.","authors":"Natalie Durieux, Elyse R Park, Daniel Hall, Jocelyn Meek, Gregory Fricchione, Darshan H Mehta, Christina Luberto","doi":"10.1177/27536130251325831","DOIUrl":"10.1177/27536130251325831","url":null,"abstract":"<p><strong>Background: </strong>Healthcare workers face an elevated risk of chronic stress and burnout, for which resiliency interventions are needed.</p><p><strong>Methods: </strong>The Stress Management and Resiliency Training Program (SMART-3RP; 8 weekly 90-minute sessions) was offered to 254 hospital employees between 2/2021 and 1/2024. Participants were surveyed pre- and post-intervention for measures of resiliency, stress coping, positive affect, perceived stress, anxiety, and depression.</p><p><strong>Results: </strong>The baseline sample was 84% female, 89.5% non-Hispanic, 71.3% White, and averaged 45 years of age (SD = 14.25). Baseline and follow-up survey completion rates were 71.3% (N = 181) and 35.8% (N = 91), respectively. Significant improvements were seen pre-post intervention for all measures (all <i>p</i>s <.001): resiliency (<i>d</i> = 0.57), stress coping (<i>d</i> = 1.1), positive affect (<i>d</i> = 0.83), perceived stress (<i>d</i> = -0.88), anxiety (<i>d</i> = -0.74), and depression (<i>d</i> = -0.43).</p><p><strong>Conclusions: </strong>Alleviating employee stress is crucial for improving individual, clinical, and systems-level outcomes in hospitals. The SMART-3RP is a promising program that provides healthcare workers with resiliency and stress coping skills.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251325831"},"PeriodicalIF":0.0,"publicationDate":"2025-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143569080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Reiki on Measures of Well-Being in Low-Income Patients with Mental Health Diagnoses.
Pub Date : 2025-02-28 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251323581
Kavita Prasad, Natalie L Dyer, Jennifer St Sauver, Mitchell S Drost, Vikas Prasad, Ann L Baldwin, Jennifer N Soderlind, Ivana T Croghan, Dietlind L Wahner-Roedler, Ahmed Hassan, Brent A Bauer

Background: More than 1 in 5 US adults live with mental illness. Novel therapies as complements to standard therapies are needed to improve patient well-being. Reiki is a biofield therapy that may improve well-being in mental health.

Objective: The primary aim of this study was to evaluate the feasibility of providing Reiki at a behavioral health clinic serving a low-income population. The secondary aim was to evaluate outcomes in terms of patients' symptoms, emotions, and feelings before and after Reiki.

Methods: This was a mixed-methods, feasibility pilot study with a pre-post experimental design. Reiki was offered to adult outpatients at a community behavioral health center in Rochester, Minnesota. Patients with a stable mental health diagnosis seen between July 22, 2021, and May 18, 2023, completed surveys before and after the Reiki intervention and provided qualitative feedback. Patients were asked to report their ratings of pain, anxiety, fatigue, and feelings (eg, happy, calm) on 0- to 10-point numeric rating scales. Data were analyzed with Wilcoxon signed rank tests.

Results: Among 91 patients who completed a Reiki session during the study period, 74 (81%) were women. Major depressive disorder (71%), posttraumatic stress disorder (47%), and generalized anxiety disorder (43%) were the most common diagnoses. The study was feasible in terms of recruitment, retention, data quality, acceptability, and fidelity of the intervention. Patient ratings of pain, fatigue, anxiety, stress, sadness, and agitation were significantly lower, and ratings of happiness, energy levels, relaxation, and calmness were significantly higher after a single Reiki session.

Conclusion: The results of this study suggest that Reiki is feasible and could be fit into the flow of clinical care in an outpatient behavioral health clinic. It improved positive emotions and feelings and decreased negative measures. Implementing Reiki in clinical practice should be further explored to improve mental health and well-being.

{"title":"Effect of Reiki on Measures of Well-Being in Low-Income Patients with Mental Health Diagnoses.","authors":"Kavita Prasad, Natalie L Dyer, Jennifer St Sauver, Mitchell S Drost, Vikas Prasad, Ann L Baldwin, Jennifer N Soderlind, Ivana T Croghan, Dietlind L Wahner-Roedler, Ahmed Hassan, Brent A Bauer","doi":"10.1177/27536130251323581","DOIUrl":"10.1177/27536130251323581","url":null,"abstract":"<p><strong>Background: </strong>More than 1 in 5 US adults live with mental illness. Novel therapies as complements to standard therapies are needed to improve patient well-being. Reiki is a biofield therapy that may improve well-being in mental health.</p><p><strong>Objective: </strong>The primary aim of this study was to evaluate the feasibility of providing Reiki at a behavioral health clinic serving a low-income population. The secondary aim was to evaluate outcomes in terms of patients' symptoms, emotions, and feelings before and after Reiki.</p><p><strong>Methods: </strong>This was a mixed-methods, feasibility pilot study with a pre-post experimental design. Reiki was offered to adult outpatients at a community behavioral health center in Rochester, Minnesota. Patients with a stable mental health diagnosis seen between July 22, 2021, and May 18, 2023, completed surveys before and after the Reiki intervention and provided qualitative feedback. Patients were asked to report their ratings of pain, anxiety, fatigue, and feelings (eg, happy, calm) on 0- to 10-point numeric rating scales. Data were analyzed with Wilcoxon signed rank tests.</p><p><strong>Results: </strong>Among 91 patients who completed a Reiki session during the study period, 74 (81%) were women. Major depressive disorder (71%), posttraumatic stress disorder (47%), and generalized anxiety disorder (43%) were the most common diagnoses. The study was feasible in terms of recruitment, retention, data quality, acceptability, and fidelity of the intervention. Patient ratings of pain, fatigue, anxiety, stress, sadness, and agitation were significantly lower, and ratings of happiness, energy levels, relaxation, and calmness were significantly higher after a single Reiki session.</p><p><strong>Conclusion: </strong>The results of this study suggest that Reiki is feasible and could be fit into the flow of clinical care in an outpatient behavioral health clinic. It improved positive emotions and feelings and decreased negative measures. Implementing Reiki in clinical practice should be further explored to improve mental health and well-being.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251323581"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11873885/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Natural Product Use for Chronic Pain: A New Survey of Patterns of Use, Beliefs, Concerns, and Disclosure to Providers.
Pub Date : 2025-02-27 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251320101
Karen H Seal, Termeh Feinberg, Liliana Moore, Nicole A Woodruff, Natalie Purcell, Daniel Bertenthal, Nicole McCamish, William R Becker

Background: "Natural products" (NPs), including dietary supplements, are widely used, yet little is known about NP use for chronic pain and related conditions.

Objective: To develop a new NP survey to better understand reasons for NP use, beliefs, concerns, medication substitution, and provider disclosure.

Methods: Based on similar surveys and input from veteran focus groups and subject matter experts, a new brief NP survey was developed. The survey was piloted among 52 veterans with chronic pain enrolled in Veterans Health Administration (VA) primary care who endorsed NP use at baseline in a pragmatic trial comparing non-drug pain management approaches. Survey data was enriched with sociodemographic and clinical data from a parent trial. Descriptive frequencies and means were calculated.

Results: Of 55 surveys, 52 were completed (response rate, 94.5%). Respondents' mean age was 57.6 (SD+/-12.5); 42% were women, 21% identified as Black/African American, and 10% Hispanic/Latinx ethnicity. All had chronic pain; 80% experienced disabling pain daily; 67% were prescribed non-opioid pain medication; 15% were prescribed opioids. In the prior 3 months, the mean number of NPs used was 4.6 (SD+/-3.2); 90% reported daily use. Most frequently used NPs were vitamins/minerals (94%), herbals/botanicals (60%); and cannabis (40%); one-third reported substituting NPs for pain medications. The majority endorsed safety concerns about interactions of NPs either with pain medications (55%) or other NPs (52%). Nearly all (98%) believed providers should discuss NP use with their patients, though only 52% had disclosed NP use to their providers.

Conclusions: Among veterans with chronic pain in VA primary care enrolled in a pragmatic trial, a new NP survey revealed prevalent use of multiple NPs concurrently, and in some cases, as substitutes for prescribed medications. Most veterans expressed safety concerns, yet a significant proportion reported not discussing NP use with their providers.

{"title":"Natural Product Use for Chronic Pain: A New Survey of Patterns of Use, Beliefs, Concerns, and Disclosure to Providers.","authors":"Karen H Seal, Termeh Feinberg, Liliana Moore, Nicole A Woodruff, Natalie Purcell, Daniel Bertenthal, Nicole McCamish, William R Becker","doi":"10.1177/27536130251320101","DOIUrl":"10.1177/27536130251320101","url":null,"abstract":"<p><strong>Background: </strong>\"Natural products\" (NPs), including dietary supplements, are widely used, yet little is known about NP use for chronic pain and related conditions.</p><p><strong>Objective: </strong>To develop a new NP survey to better understand reasons for NP use, beliefs, concerns, medication substitution, and provider disclosure.</p><p><strong>Methods: </strong>Based on similar surveys and input from veteran focus groups and subject matter experts, a new brief NP survey was developed. The survey was piloted among 52 veterans with chronic pain enrolled in Veterans Health Administration (VA) primary care who endorsed NP use at baseline in a pragmatic trial comparing non-drug pain management approaches. Survey data was enriched with sociodemographic and clinical data from a parent trial. Descriptive frequencies and means were calculated.</p><p><strong>Results: </strong>Of 55 surveys, 52 were completed (response rate, 94.5%). Respondents' mean age was 57.6 (SD+/-12.5); 42% were women, 21% identified as Black/African American, and 10% Hispanic/Latinx ethnicity. All had chronic pain; 80% experienced disabling pain daily; 67% were prescribed non-opioid pain medication; 15% were prescribed opioids. In the prior 3 months, the mean number of NPs used was 4.6 (SD+/-3.2); 90% reported daily use. Most frequently used NPs were vitamins/minerals (94%), herbals/botanicals (60%); and cannabis (40%); one-third reported substituting NPs for pain medications. The majority endorsed safety concerns about interactions of NPs either with pain medications (55%) or other NPs (52%). Nearly all (98%) believed providers should discuss NP use with their patients, though only 52% had disclosed NP use to their providers.</p><p><strong>Conclusions: </strong>Among veterans with chronic pain in VA primary care enrolled in a pragmatic trial, a new NP survey revealed prevalent use of multiple NPs concurrently, and in some cases, as substitutes for prescribed medications. Most veterans expressed safety concerns, yet a significant proportion reported not discussing NP use with their providers.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251320101"},"PeriodicalIF":0.0,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869316/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Green Healthcare - Collective Wellbeing for People and Planet.
Pub Date : 2025-02-27 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251317173
Farah Shroff, Lumas Helaire

Background: As global climate change accelerates, the crisis of species survival invites holistic ways of knowing. There is a resurgence of engagement in Indigenous spiritual wellbeing systems as part of anti-colonial liberation movements. Green collective wellbeing systems (GreenCoWell) offer opportunities to heal both people and the planet, addressing the notion of separation between life forms.

Objective: We plan to study and elaborate upon 6 BIPOC health practices based on interconnection, including family constellation healing (Zulu nation, Southern Africa), fa (Ghana), yoga (India), shinrinyoku (Japan), Danza Azteca (Central America), and one practice to be identified in the course of the study. From a feminist, anti-racism and decolonial lens, our work aims to support ways of knowing which originate from the Global South and Indigenous communities.

Methods: Applying a participatory action research approach, we will blend qualitative and arts-based methods to portray 6 global GreenCoWell. Healers from each tradition will be interviewed separately and will engage in a collective dialogue on the desire, need, and methods for proliferating GreenCoWell systems.

Results: The results of this project will be a film, poems, stories, academic products, social media messages, and a manifesto emanating from the collective dialogue.

Conclusion: This mixed methods arts-based, feminist, anti-racism, and decolonial project brings together healers from 6 traditions, representing a novel approach to addressing climate change. Those who practice GreenCoWell engage in environmental conservation. Our long term aspiration is for more people to experience mental, physical, and spiritual wellbeing through these and related GreenCoWell and take action for climate justice.

{"title":"Green Healthcare - Collective Wellbeing for People and Planet.","authors":"Farah Shroff, Lumas Helaire","doi":"10.1177/27536130251317173","DOIUrl":"https://doi.org/10.1177/27536130251317173","url":null,"abstract":"<p><strong>Background: </strong>As global climate change accelerates, the crisis of species survival invites holistic ways of knowing. There is a resurgence of engagement in Indigenous spiritual wellbeing systems as part of anti-colonial liberation movements. Green collective wellbeing systems (GreenCoWell) offer opportunities to heal both people and the planet, addressing the notion of separation between life forms.</p><p><strong>Objective: </strong>We plan to study and elaborate upon 6 BIPOC health practices based on interconnection, including family constellation healing (Zulu nation, Southern Africa), fa (Ghana), yoga (India), shinrinyoku (Japan), Danza Azteca (Central America), and one practice to be identified in the course of the study. From a feminist, anti-racism and decolonial lens, our work aims to support ways of knowing which originate from the Global South and Indigenous communities.</p><p><strong>Methods: </strong>Applying a participatory action research approach, we will blend qualitative and arts-based methods to portray 6 global GreenCoWell. Healers from each tradition will be interviewed separately and will engage in a collective dialogue on the desire, need, and methods for proliferating GreenCoWell systems.</p><p><strong>Results: </strong>The results of this project will be a film, poems, stories, academic products, social media messages, and a manifesto emanating from the collective dialogue.</p><p><strong>Conclusion: </strong>This mixed methods arts-based, feminist, anti-racism, and decolonial project brings together healers from 6 traditions, representing a novel approach to addressing climate change. Those who practice GreenCoWell engage in environmental conservation. Our long term aspiration is for more people to experience mental, physical, and spiritual wellbeing through these and related GreenCoWell and take action for climate justice.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251317173"},"PeriodicalIF":0.0,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11869250/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating Feasibility and Acceptability of a Telehealth Integrative Pain Management Program Among Primary Care Safety-Net Patients.
Pub Date : 2025-02-26 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251321460
Shivani Bahl, Vadan Ritter, Ariana Thompson-Lastad, Denise Ruvalcaba, Jhia Jackson, Christa M Fernando, Candice Turchin, Mary Ann Finch, Antonella Soldaini, Pamela Swedlow, Jesse Wennik, Maria T Chao

Background: The COVID-19 pandemic exacerbated pain care inequities for low-income people. The Telehealth Integrative Pain Management Program (t-IPMP) was developed to provide pain management services for patients in public health clinics of the San Francisco Health Network (SFHN). Adapted from an existing program, t-IPMP delivered multimodal pain treatment via telehealth groups when in-person healthcare was restricted.

Objective: This mixed-methods study evaluates the feasibility and acceptability of t-IPMP.

Methods: We conducted a single-arm evaluation of three cohorts of t-IPMP, comprising 12 two-hour weekly online sessions on pain education, mindfulness, therapeutic movement, and self-acupressure. Participants were adults with chronic pain referred by SFHN primary care providers. We conducted baseline surveys, three-month surveys, and qualitative interviews (n = 15); participant observation of three sessions per cohort; and 3 focus groups (n = 20). Mixed-methods analysis included descriptive statistics, pre/post comparisons using t-tests, and codebook thematic analysis.

Results: The t-IPMP received 107 referrals from 52 providers at 11 clinics, and 35% of referrals enrolled. Participants (n = 37) attended an average of 6 sessions. Participants who completed surveys (n = 15) were majority cisgender women (67%) with below-average wealth (87%) from diverse racial and ethnic identities. Qualitative data highlighted that t-IPMP created a supportive environment which fostered social connection and reduced social isolation. Social support encouraged use of new mind-body practices for pain. Telehealth was well received, though some participants preferred in-person interaction. From baseline to three-month follow up, average scores increased on measures of physical function (mean = 1.9, 95% CI 0.2-3.6); global quality of life (mean = 3.8, 95% CI 1.6-6.0); and pain self-efficacy (mean = 5.3, 95% CI 0.9-9.7).

Conclusion: Integrative, multimodal pain management delivered through telehealth groups is feasible among primary care safety net patients, however, may not be optimal for all. Findings indicate that offering options for participating either online or in-person may best address patient needs and preferences.

背景:COVID-19 大流行加剧了低收入人群在疼痛护理方面的不平等。远程健康综合疼痛管理计划(t-IPMP)的制定旨在为旧金山健康网络(SFHN)公共卫生诊所的患者提供疼痛管理服务。t-IPMP 根据现有计划改编,在现场医疗服务受到限制的情况下,通过远程医疗小组提供多模式疼痛治疗:这项混合方法研究评估了 t-IPMP 的可行性和可接受性:我们对 t-IPMP 的三个组别进行了单臂评估,包括每周 12 次、每次两小时的在线课程,内容涉及疼痛教育、正念、治疗性运动和自我按压。参与者是由 SFHN 初级保健提供者转介的慢性疼痛成人患者。我们进行了基线调查、为期三个月的调查和定性访谈(n = 15);对每个组群的三次课程进行了参与者观察;以及 3 个焦点小组(n = 20)。混合方法分析包括描述性统计、使用 t 检验的前后比较和编码本主题分析:t-IPMP 共收到来自 11 家诊所 52 名医疗服务提供者的 107 份转介申请,其中 35% 的转介申请者加入了该计划。参与者(37 人)平均参加了 6 次治疗。完成调查的参与者(n = 15)大多是顺性别女性(67%),财富低于平均水平(87%),来自不同的种族和民族。定性数据强调,t-IPMP 创造了一个支持性环境,促进了社会联系,减少了社会隔离。社会支持鼓励人们使用新的身心疗法来治疗疼痛。尽管有些参与者更喜欢面对面的交流,但远程医疗还是受到了欢迎。从基线到三个月的随访,身体功能(平均 = 1.9,95% CI 0.2-3.6)、整体生活质量(平均 = 3.8,95% CI 1.6-6.0)和疼痛自我效能(平均 = 5.3,95% CI 0.9-9.7)的平均得分均有所提高:结论:通过远程医疗小组提供综合、多模式疼痛管理在初级保健安全网患者中是可行的,但并非对所有人都是最佳选择。研究结果表明,提供在线或面对面参与的选择可能最能满足患者的需求和偏好。
{"title":"Evaluating Feasibility and Acceptability of a Telehealth Integrative Pain Management Program Among Primary Care Safety-Net Patients.","authors":"Shivani Bahl, Vadan Ritter, Ariana Thompson-Lastad, Denise Ruvalcaba, Jhia Jackson, Christa M Fernando, Candice Turchin, Mary Ann Finch, Antonella Soldaini, Pamela Swedlow, Jesse Wennik, Maria T Chao","doi":"10.1177/27536130251321460","DOIUrl":"10.1177/27536130251321460","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic exacerbated pain care inequities for low-income people. The Telehealth Integrative Pain Management Program (t-IPMP) was developed to provide pain management services for patients in public health clinics of the San Francisco Health Network (SFHN). Adapted from an existing program, t-IPMP delivered multimodal pain treatment via telehealth groups when in-person healthcare was restricted.</p><p><strong>Objective: </strong>This mixed-methods study evaluates the feasibility and acceptability of t-IPMP.</p><p><strong>Methods: </strong>We conducted a single-arm evaluation of three cohorts of t-IPMP, comprising 12 two-hour weekly online sessions on pain education, mindfulness, therapeutic movement, and self-acupressure. Participants were adults with chronic pain referred by SFHN primary care providers. We conducted baseline surveys, three-month surveys, and qualitative interviews (n = 15); participant observation of three sessions per cohort; and 3 focus groups (n = 20). Mixed-methods analysis included descriptive statistics, pre/post comparisons using t-tests, and codebook thematic analysis.</p><p><strong>Results: </strong>The t-IPMP received 107 referrals from 52 providers at 11 clinics, and 35% of referrals enrolled. Participants (n = 37) attended an average of 6 sessions. Participants who completed surveys (n = 15) were majority cisgender women (67%) with below-average wealth (87%) from diverse racial and ethnic identities. Qualitative data highlighted that t-IPMP created a supportive environment which fostered social connection and reduced social isolation. Social support encouraged use of new mind-body practices for pain. Telehealth was well received, though some participants preferred in-person interaction. From baseline to three-month follow up, average scores increased on measures of physical function (mean = 1.9, 95% CI 0.2-3.6); global quality of life (mean = 3.8, 95% CI 1.6-6.0); and pain self-efficacy (mean = 5.3, 95% CI 0.9-9.7).</p><p><strong>Conclusion: </strong>Integrative, multimodal pain management delivered through telehealth groups is feasible among primary care safety net patients, however, may not be optimal for all. Findings indicate that offering options for participating either online or in-person may best address patient needs and preferences.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251321460"},"PeriodicalIF":0.0,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11866383/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143525492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heals on Wheels: Development and Implementation of Community Outreach and Group Medical Visits for People Experiencing Chronic Pain.
Pub Date : 2025-02-24 eCollection Date: 2025-01-01 DOI: 10.1177/27536130251322501
Catherine Justice, Susan Haddow, Katherine Shafto, Tegan Reeves, Jadyn E Knox, Arti Prasad

Background: Chronic pain is a global problem affecting approximately 20% of adults. The prevalence of opioid use for chronic pain has contributed to a widespread crisis of addiction and inadequately managed pain. Though national and international guidelines recommend nonpharmacological, integrative, multi-modal therapies for chronic pain, numerous systemic barriers limit access to these services for those with the highest need and fewest resources.

Objective: This paper describes the development and testing of an innovative "Heals on Wheels" (HoW) community engagement and Group Medical Visit (GMV) program for underserved communities experiencing chronic pain in Hennepin County, Minnesota.

Methods: The HoW program's curriculum was collaboratively adapted from pre-existing Hennepin Health care GMV programs for chronic pain. Free community-based "Appetizer" workshops were developed alongside an 8-week "Full Meal" GMV program titled Easing Pain Holistically (EPH). Three pain-affinity variations of EPH were created (the "Body", "Head", and "Heart") and delivered to 6 cohorts (2 cohorts of each variation). Feasibility was measured by attendance, demographics, and insurance provider information. To evaluate program acceptability, thematic analysis of patients post-GMV weekly progress sheets was performed.

Results: The curriculum for the HoW program included experiential training and education in evidence-based integrative pain management strategies. Fourteen community appetizer workshops (n = 142) were offered in partnership with organizations representing underserved populations. Fifty-five patients completed EPH from 2022 to 2024 with the greatest number of patients in the Heart (n = 23), followed by the Body (n = 19), and the Head (n = 13). Feasibility for the GMV program was demonstrated with average attendance across 6 cohorts at 75.1%. Thematic analysis of qualitative data revealed themes highlighting appreciation for group connection ("sharing") and the EPH program content.

Conclusion: The HoW program shows promise as a feasible and acceptable model of community outreach and engagement to improve access to evidence-based integrative pain care.

{"title":"Heals on Wheels: Development and Implementation of Community Outreach and Group Medical Visits for People Experiencing Chronic Pain.","authors":"Catherine Justice, Susan Haddow, Katherine Shafto, Tegan Reeves, Jadyn E Knox, Arti Prasad","doi":"10.1177/27536130251322501","DOIUrl":"10.1177/27536130251322501","url":null,"abstract":"<p><strong>Background: </strong>Chronic pain is a global problem affecting approximately 20% of adults. The prevalence of opioid use for chronic pain has contributed to a widespread crisis of addiction and inadequately managed pain. Though national and international guidelines recommend nonpharmacological, integrative, multi-modal therapies for chronic pain, numerous systemic barriers limit access to these services for those with the highest need and fewest resources.</p><p><strong>Objective: </strong>This paper describes the development and testing of an innovative \"Heals on Wheels\" (HoW) community engagement and Group Medical Visit (GMV) program for underserved communities experiencing chronic pain in Hennepin County, Minnesota.</p><p><strong>Methods: </strong>The HoW program's curriculum was collaboratively adapted from pre-existing Hennepin Health care GMV programs for chronic pain. Free community-based \"Appetizer\" workshops were developed alongside an 8-week \"Full Meal\" GMV program titled <i>Easing Pain Holistically</i> (EPH). Three pain-affinity variations of EPH were created (the \"Body\", \"Head\", and \"Heart\") and delivered to 6 cohorts (2 cohorts of each variation). Feasibility was measured by attendance, demographics, and insurance provider information. To evaluate program acceptability, thematic analysis of patients post-GMV weekly progress sheets was performed.</p><p><strong>Results: </strong>The curriculum for the HoW program included experiential training and education in evidence-based integrative pain management strategies. Fourteen community appetizer workshops (n = 142) were offered in partnership with organizations representing underserved populations. Fifty-five patients completed EPH from 2022 to 2024 with the greatest number of patients in the Heart (n = 23), followed by the Body (n = 19), and the Head (n = 13). Feasibility for the GMV program was demonstrated with average attendance across 6 cohorts at 75.1%. Thematic analysis of qualitative data revealed themes highlighting appreciation for group connection (\"sharing\") and the EPH program content.</p><p><strong>Conclusion: </strong>The HoW program shows promise as a feasible and acceptable model of community outreach and engagement to improve access to evidence-based integrative pain care.</p>","PeriodicalId":73159,"journal":{"name":"Global advances in integrative medicine and health","volume":"14 ","pages":"27536130251322501"},"PeriodicalIF":0.0,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11851801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143506533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Global advances in integrative medicine and health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1